IDH2 and acute myeloid leukemia: High frequency mutations in IDH2 have been detected in AML, including chondrosarcoma, glioma, solid papillary carcinoma with reverse polarity and angioimmunoblastic T cell lymphoma (Yang et al., 2012; Guo et al., 2021).